• Ipsen pens early-stage, $14.5M programmed cell death cancer deal with BAKX Therapeutics

    1 month ago - By Fierce Biotech

    Ipsen pens early-stage, $14.5M programmed cell death cancer deal with BAKX Therapeutics badams
    Wed, 07/28/2021 - 09:00
    Read more ...